Company: NCEL
Filing Date: 2025-10-24
Form Type: POS AM
Source: 0001213900-25-102149
Chunk: 30

Company: NewcelX Ltd.
Filing Date: 2025-10-24
Form: POS AM
Chunk 30
---
 statements. We discuss many of these risks in this prospectus in greater detail under the heading “Risk Factors”
on page 13 of this prospectus. You should not rely upon forward-looking statements as predictions of future events.

Although
we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels
of activity, performance, or achievements. Except as required by law, we are under no duty to update or revise any of the forward-looking
statements, whether or not, as a result of new information, future events or otherwise, after the date of this prospectus.

<div align='center'>16

USE OF PROCEEDS</div>

This prospectus relates to
our Common Shares that may be offered and sold from time-to-time by the Selling Shareholder. All of the Common Shares offered by the Selling
Shareholder pursuant to this prospectus will be sold by the Selling Shareholder for its own account. We will not receive any of the proceeds
from these sales.

We may receive up to $25.0
million aggregate gross proceeds under the Purchase Agreement from any sales we make to the Selling Shareholder pursuant to the Purchase
Agreement. To date, we have not sold any Common Shares (other than the Commitment Shares), pursuant to the Purchase Agreement. However,
we are unable to estimate the actual amount of proceeds that we may receive, as it will depend on the number of shares that we choose
to sell, our ability to meet the conditions to purchases set forth in Purchase Agreement, market conditions and the price of our Common
Shares, among other factors.

We expect to use any proceeds
that we receive under the Purchase Agreement for working capital, which includes research and development to advance our technology, general
corporate purposes, and pursuing strategic opportunities which include expanding our pipeline and investments in other companies that
may not necessarily be aligned with our current business strategy. We cannot provide any assurance that we will be able to carry out any
potential investments we may identify. As of the date of this prospectus, we cannot specify with certainty all of the particular uses,
and the respective amounts we may allocate to those uses, for any net proceeds we receive. Accordingly, we will retain broad discretion
over the use of these proceeds.

<div align='center'>DIVIDEND POLICY</div>

We
have never declared or paid any cash dividends on our Common Shares and do not anticipate paying any cash dividends in the foreseeable
future. Payment of cash dividends, if any